fine-needle aspiration, 114 history and physical examination, 114 , 114 t mammography, 114 fibroadenoma, 111 fibrocystic disease, 111 –112 gynecomastia, 113 –114 juvenile breast hypertrophy, 113 life-threatening, 111 t physiologic mastalgia, 114 premature thelarche, 113 ultrasonography, 112 Breast milk jaundice, 295 , 298 Breath-holding spells, 518 , 882 Breathing abnormalities, 1224 assessment of, 29 CPR management, 49 –50 , 50 f evaluation, 49 Brief psychotic episode, 1440 –1442 Brief resolved unexplained events (BRUE), 102 , 103 t, 143 Bronchial atresia, 1407 Bronchial foreign body, 1119 f Bronchiectasis, 574 Bronchiolitis, 133 –136 , 134 t, 480 , 569 Bronchogenic cysts, 1405 , 1415 , 1417 f Bronchopulmonary dysplasia, 944 –945 , 945 f Bronchopulmonary sequestrations (BPSs), 1415 Bronchoscopy, 1406 , 1409 Brown-Séquard syndrome, 1250 , 1250 f Brucella, 848 , 1349 Brucellosis, 313 Brudzinski sign, 123 Brugada syndrome, 519 , 522 Bruise, 624 –625 Bruising, 623 –624 Bubonic plague, 253 Buccal mucosa laceration, 1167 Bulbar urethritis, 384 t Bulimia nervosa, 570 Bullous impetigo, 439 , 439 f Bullous pemphigoid, 448 Burkholderia cepacia , 946 Burkitt lymphoma, 909 Burns, 624 –625 , 1095 –1103 chemical, 1102 –1103 clinical assessment, 1096 –1097 clinical recognition, 1096 electrical, 1102 emergency care, goals of, 1095 fluid resuscitation formulas, 1100 t inflicted, 1102 initial assessment, 1095 –1098 evidences, 1095 –1096 treatment goals, 1096 major clinical assessment, 1098 –1099 clinical recognition, 1098 evidences, 1098 treatment goals, 1098 triage considerations, 1096 t, 1098 management, 1097 –1099 antibiotics, 1100 blisters, 1101 breathing, 1099 circulation, 1099 disposition, 1101 dressing, 1101 –1102 escharotomy, 1100 fluid resuscitation, 1099 –1100 pain, 1100 –1101 tetanus, 1100 wound care, 1100 meticulous antiseptic techniques, 1100 minor, 1101 –1102 partial-thickness, 1096 –1097 resuscitation, 1095 –1098 skin, classification, 1097 f superficial, 1096 , 1097 f surface area, estimation, 1097 f triage considerations, 1096 , 1096 t various depths, 1098 f Bursitis, 405 Button battery, 206 , 208 C Café-au-lait spots, 466 Calcifications, 1307 Calcium channel blockers (CCBs), 1044 Calcium chloride, 55 t Calcium gluconate, 55 t Campylobacter jejuni infection, 218 , 558 , 893 Canale–Smith syndrome, 312 Cancers of breast, 112 Candida albicans , 347 , 458 , 462 –463 , 510 , 534 , 1342 Candida infection, 443 –444 , 443 f Candidal diaper dermatitis, 458 , 463 Candidal vulvovaginitis, 530 , 543 Candida psiloparis , 458 Candida vaginitis, 545 Candidiasis, 347 Cannabis poisoning, 1073 –1074 Cannabis sativa , 337 Capnography, 40 Carbamate insecticides, 1065 Carbamazepine, 456 Carbon monoxide poisoning, 503 , 685 –687 Carbohydrate disorders, 878 intolerance, 878 production, 878 Carbon monoxide poisoning clinical recognition, 686 indications for discharge/admission, 687 management and diagnostic studies, 686 –687 , 687 t treatment, goals of, 685 triage considerations, 686 Carboxyhemoglobinemia, 123 Carcinomas, 910 Cardiac arrest pathways, 45 f signs and symptoms of lack of oxygen/glucose, 47 f Cardiac Arrest Registry to Enhance Survival (CARES), 44 , 57 Cardiac emergencies acquired heart disease, 611 –612 acute heart failure syndromes (AHFS), 610 –611 , 611 t, 612 f acute rheumatic fever, 614 arrhythmic emergencies, 600 –609 bacterial endocarditis, 614 cardiac tamponade, 614 cardiac trauma, 615 –616 cardiomyopathies, 612 –613 congenital heart disease (CHD), 588 –600 Kawasaki disease (KD), 615 myocardial ischemia (MI), 615 myocarditis, 613 patient evaluation with cardiac device, 616 –618 pericarditis, 613 –614 sudden cardiac death, 609 –610 , 611 f therapy goals of, 588 Cardiac infections brucella, 848 Chagas disease, 846 coronaviruses, 846 diphtheria, 847 lymphadenopathy, 847 measles, 847 mumps, 847 –848 Cardiac infectious emergencies acquired heart disease, 611 ... chemical, 1102 –1103 clinical assessment, 1096 –1097 clinical recognition, 1096 electrical, 1102 emergency care, goals of, 1095 fluid resuscitation formulas, 1100 t inflicted, 1102 initial assessment,